| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000049042 |
| Receipt No. | R000055793 |
| Scientific Title | A study of the effect of test food on the mental and physical condition. -randomized, placebo-controlled, double-blind, parallel-group trial- |
| Date of disclosure of the study information | 2023/10/01 |
| Last modified on | 2022/09/27 (Ver. 1) |
| Basic information | ||
| Public title | A study of the effect of test food on the mental and physical condition. -randomized, placebo-controlled, double-blind, parallel-group trial- | |
| Acronym | A study of the effect of test food on the mental and physical condition. | |
| Scientific Title | A study of the effect of test food on the mental and physical condition. -randomized, placebo-controlled, double-blind, parallel-group trial- | |
| Scientific Title:Acronym | A study of the effect of test food on the mental and physical condition. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy subjects | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This trial aims to investigate the effect of 8 weeks intake of the test food on the mental and physical condition in healthy subjects. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | QOL questionnaire
intestinal microbiota blood markers test |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Take test food with water or warm water for 8 weeks. | |
| Interventions/Control_2 | Take placebo food with water or warm water for 8 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1. Healthy subjects over 18 years old
2. Those who received the sufficient explanation for the objective and summary of the trial, voluntarily decided to participate in the trial after understanding the purpose and made the written agreement Those who have no history of smoking within a year |
|||
| Key exclusion criteria | 1. Those who have been currently visiting a hospital or treated with any drug for any disease
2. Those who currently have or have history of severe diseases 3. Those who joined other clinical trials within 1 month before receiving informed consent in this study, or those who are currently joining other clinical trials 4. Those who are judged by the physician to be unsuitable for this study. 5. Those who are currently pregnant, breastfeeding or planning to get pregnant during the study period. |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Taiyo Kagaku Co., Ltd | ||||||
| Division name | Nutrition Division | ||||||
| Zip code | 510-0844 | ||||||
| Address | 1-3 Takaramachi, Yokkaichi, Mie 510-0844, Japan | ||||||
| TEL | 059-347-5411 | ||||||
| mozeki@taiyokagaku.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Taiyo Kagaku Co., Ltd | ||||||
| Division name | Nutrition Division | ||||||
| Zip code | 510-0844 | ||||||
| Address | 1-3 Takaramachi, Yokkaichi, Mie 510-0844, Japan | ||||||
| TEL | 059-347-5411 | ||||||
| Homepage URL | |||||||
| aabe@taiyokagaku.co.jp | |||||||
| Sponsor | |
| Institute | Seitoku University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Taiyo Kagaku Co., Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Seitoku university ethics committee for human study |
| Address | 550 Iwase, Matsudo-shi, Chiba, 271-8555, Japan |
| Tel | 047-365-1111 |
| ethics.committee@wa.seitoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055793 |